Peer-reviewed science, in the record.

Theertha's research is published in the peer-reviewed literature and contributes to the wider scientific community — across mesenchymal stem-cell biology, extracellular vesicles, synthetic-biology approaches to cell therapy, and protein characterization.

Publications

Company-affiliated research.

2023

Theertha R&D · Stem-cell biology

Inhibition of LPS-Induced Inflammatory Response of Oral Mesenchymal Stem Cells in the Presence of Galectin-3

Biomedicines · 24 May 2023

Thangavelu Soundara Rajan — Research & Development Unit, Theertha Biopharma Private Limited, Bengaluru.

DOI: 10.3390/biomedicines11061519

2024

Theertha R&D · Extracellular vesicles

Extracellular vesicles (EVs): A promising therapeutic tool in the heart tissue regeneration

BioFactors

Thangavelu Soundara Rajan — Research & Development Unit, Theertha Biopharma, Bengaluru. Relevant to Theertha's exosome / EV platform.

2025

Theertha R&D · Synthetic biology / cell therapy

Microbial Systems Enhancing CAR-Based Therapies: A Synthetic Biology Paradigm for Next-Generation Cancer Immunotherapy

Current Microbiology · 27 December 2025

Sameer Kumar Singdevsachan — Theertha Biopharma Pvt. Ltd. (with co-authors from Hoynoza Technologies and Manipal Centre for Biotherapeutics Research).

DOI: 10.1007/s00284-025-04679-z · PMID 41454921

Analytical & collaborative contributions

Supporting the science of others.

Theertha also contributes specialised analytical capability to external research programmes.

2026

Analytical contribution · SEC

Terminal residues modulate DNA-binding site size and stability of the SSB-like DNA-binding protein Gp13 from bacteriophage Phi11

Size-exclusion chromatography (SEC) analysis of Gp13 and its deletion mutants performed by Theertha Biopharma Pvt. Ltd., Bengaluru (Yarra SEC 2000 column).

Listed as a scientific / analytical collaboration — not a Theertha-authored publication.

Patents & intellectual property

Protecting our platforms.

Theertha's patent and intellectual-property portfolio is being compiled. Verified filings — with title, application number, inventors, status and official links — will be published here.

Collaborate with us

Research partnerships and analytical services.

From joint research to specialised characterization, our R&D team works with academic and industry partners worldwide.

Contact the team